| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883707 Induction of antigen specific immunnologic tolerance |
| 02/08/2011 | CA2641585C Capsular polysaccharide solubilisation and combination vaccines |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2586179C Sulfonyl benzimidazole derivatives |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2403292C Microbial delivery system |
| 02/08/2011 | CA2341574C Phosphohalohydrins, method for making same and uses |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
| 02/03/2011 | WO2011014775A1 Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses |
| 02/03/2011 | WO2011014659A2 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | WO2011014515A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors |
| 02/03/2011 | WO2011014438A1 Fully human antibodies to btla |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013729A1 Fused imidazole derivative having ttk inhibitory action |
| 02/03/2011 | WO2011013568A1 Immunosuppressive γδt cell |
| 02/03/2011 | WO2011013496A1 Process for preparation of aphanothece sacrum-originated polysaccharide with reduced trivalent metal content |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011013398A1 Compound having high affinity for cd22 molecule and capable of enhancing proliferation of b cells |
| 02/03/2011 | WO2011012883A1 Benzo [e] [1, 3 ] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors |
| 02/03/2011 | WO2011012540A1 Tricyclic inhibitors of jak |
| 02/03/2011 | WO2011012534A1 Plk inhibitor salts |
| 02/03/2011 | WO2011012240A2 Lipopeptides for therapy and prophylaxis of allergic illnesses |
| 02/03/2011 | WO2011011984A1 Sterol derivatives and their synthesis and use |
| 02/03/2011 | WO2011011873A1 Sticky soft gel for treating poultry |
| 02/03/2011 | WO2010133472A3 Growing up milks containing probiotic micro-organisms |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028478 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028449 Novel aminomethyl benzene derivatives |
| 02/03/2011 | US20110028417 Macrocyclic Compounds and Methods of Use Thereof |
| 02/03/2011 | US20110028411 Alpha-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 02/03/2011 | US20110028410 Use of Amygdalin Analogues for the Treatment of Psoriasis |
| 02/03/2011 | US20110028409 Detection of anti-ribosomal p protein antibodies by means of synthetic peptides |
| 02/03/2011 | US20110028406 Pharmaceutical Compositions Comprising A Cyclosporin, A Hydrophilic Surfactant and a Lipophilic Surfactant |
| 02/03/2011 | US20110028405 Sulfamides as zap-70 inhibitors |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027376 Hollow Multi-Layered Microspheres for Delivery of Hydrophilic Active Compounds |
| 02/03/2011 | US20110027339 Porous implants and stents as controlled release drug delivery carriers |
| 02/03/2011 | US20110027327 Cosmetic or pharmaceutical composition for topical application |
| 02/03/2011 | US20110027323 Adjuvants and methods of use |
| 02/03/2011 | US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides |
| 02/03/2011 | US20110027319 Methods of eliciting or boosting a cellular immune response |
| 02/03/2011 | US20110027318 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
| 02/03/2011 | US20110027315 Protein cages and their uses |
| 02/03/2011 | US20110027314 Influenza Vaccines Containing Hemagglutinin and Matrix Proteins |
| 02/03/2011 | US20110027312 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| 02/03/2011 | US20110027310 Compositions and Methods for Cancer Treatment |
| 02/03/2011 | US20110027309 Compositions and methods of enhancing immune responses |
| 02/03/2011 | US20110027308 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 02/03/2011 | US20110027307 Anti-sepsis conjugate vaccine |
| 02/03/2011 | US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods |
| 02/03/2011 | US20110027304 Yersinia pestis antigens, vaccine compositions and related methods |
| 02/03/2011 | US20110027301 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027298 Microbial delivery system |
| 02/03/2011 | US20110027295 Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses |
| 02/03/2011 | US20110027290 Anti-il-17 antibodies |
| 02/03/2011 | US20110027286 High Affinity Human Antibodies to Human Angiopoietin-2 |
| 02/03/2011 | US20110027282 Interferon antagonists, antibodies thereto and associated methods of use |
| 02/03/2011 | US20110027281 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor |
| 02/03/2011 | US20110027272 Stabilized liquid anti-rsv antibody formulations |
| 02/03/2011 | US20110027271 Antibody composition exhibiting cellular cytotoxicty due to glycosylation |
| 02/03/2011 | US20110027265 Methods and Compositions Related to Immunizing Against Staphylococcal Lung Diseases and Conditions |
| 02/03/2011 | US20110027259 Component of bromelain |
| 02/03/2011 | US20110027242 Method for production of transfected cell |
| 02/03/2011 | US20110027220 Interleukin-1 Conjugates and Uses Thereof |
| 02/03/2011 | US20110027218 Tnf superfamily fusion proteins |
| 02/03/2011 | US20110027217 Immunomodulatory agent-polymeric compounds |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | DE102009034779A1 Synthetische Analoga bakterieller Lipopeptide und ihre Anwendung zur Therapie und Prophylaxe allergischer Erkrankungen Synthetic analogues of bacterial lipopeptides and their use for the therapy and prophylaxis of allergic diseases |
| 02/03/2011 | CA2769752A1 Adenoviral-based vectors |
| 02/03/2011 | CA2769623A1 Treatment of crohn's disease with laquinimod |
| 02/03/2011 | CA2769518A1 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | CA2769473A1 Fully human antibodies to btla |
| 02/03/2011 | CA2769223A1 Sticky soft gel for treating poultry |
| 02/03/2011 | CA2768997A1 High yield yellow fever virus strain with increased propagation in cells |
| 02/03/2011 | CA2768552A1 Programming of cells for tolerogenic therapies |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2763628A1 Tricyclic inhibitors of jak |
| 02/02/2011 | EP2280074A2 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279751A2 Stabilisation of macrolides |
| 02/02/2011 | EP2279748A1 Multivalent vaccine composition |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | EP2279741A2 Caprolactams and their use as anti-inflammatory agents |
| 02/02/2011 | EP2279412A2 Novel compositions and methods for the treatment of immune related diseases |
| 02/02/2011 | EP2279246A2 Methods and compositions for modulating immunological tolerance |
| 02/02/2011 | EP2279208A1 Single domain antibodies that bind il-13 |